Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2024 07:45 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults

Plasma levels of inflammasome ASC show promise as a biomarker of early cognitive decline in older adults.